- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:59 | European Commission approves 2nd IPCEI to sum of €403m | ||
| 14:59 | AI health tech Respiree closes $11.6m Series A | ||
| 13:59 | Replimune receives CRL on BLA for RP1 for advanced melanoma | ||
| Di | Scancell points to 'strong' melanoma vaccine data | ||
| Di | AstraZeneca reveals $50bn investment in US facilities | ||
| Di | Sarepta backs down and pauses Elevidys shipments | ||
| Di | Sanofi to buy UK vaccines developer Vicebio for $1.6bn | ||
| Mo | FDA names a new CDER director, choosing a biotech vet | ||
| Mo | First-in-class hay fever immunotherapy backed for NHS use | ||
| Mo | Survival data back Tagrisso's role in first-line lung cancer | ||
| Mo | Merck's SpringWorks takeover delivers a drug approval | ||
| Mo | Roche's COPD candidate fails a phase 3 readout | ||
| Mo | Sarepta resists as FDA seeks pause on Elevidys use | ||
| Fr | Third death reported with a Sarepta gene therapy | ||
| Fr | BMS, Pfizer take DTC route for blood thinner Eliquis | ||
| Fr | GSK's growth plans dented by Blenrep setback | ||
| Fr | UK plans to invest 'billions' in Essex biosecurity centre | ||
| Do | Medical chatbot firm OpenEvidence raises $210m | ||
| Do | NICE relents and backs Kisqali for wide use in breast cancer | ||
| Do | EVERSANA unveils new AI-powered pharmacovigilance suite | ||
| Do | Four AIs for spinal fractures can be used by NHS, says NICE | ||
| Do | Bayer extends CEO contract amid 'signs of success' | ||
| Do | UK plan to lead life sciences gets mixed response | ||
| 16.07. | NHS trust rolls out digital health tool for kidney disease | ||
| 16.07. | FDA fast-tracks Sanofi's gene therapy for eye disease GA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .